BD Announces CE Mark of Portable, Rapid Point-of-Care Antigen Test to Detect SARS-CoV-2 in 15 Minutes
SARS-CoV-2 Assay for BD Veritor™ Plus System to be available in Europe by end of October
Point of Care
Collect and Transfer Micro Samples With Accuracy, Precision, and Ease
Innovative solutions for capillary transfer and exact volume pipetting
Engineers Develop Innovative Technology for Roadside Cannabis Testing
With recent changes in the legalization of cannabis around the world, there is an urgent need for rapid, yet sensitive, screening devices for testing drivers and employees under the influence of cannabis at roadside and workplace
Developing New Technology to Address Antibiotic Resistance
System for assessing urinary tract infections at the point of care, and determining optimal antibiotic course, is on track for initial trials in 2020
Avacta and Cytiva Ahead of Schedule on COVID-19 Rapid Test
Avacta successfully generates several highly specific Affimer reagents for COVID-19 antigen rapid test ahead of schedule as part of Cytiva partnership
Could We Monitor COVID-19 Virus Like We Do Air Pollution?
A new biosensor could provide another diagnostic option, as well as eventually detect viral particles in the air of crowded public spaces
An Instrument-Free Molecular Diagnostic Test for COVID-19
Pioneering new class of diagnostic product will transform fight against pandemic
Dolomite and Mologic Collaborate to Scale-Up Manufacture of Nanoparticles for COVID-19 Diagnostic Tests
The technology behind rapid COVID-19 tests involves the use of precisely manufactured nanoparticles
Avacta and Cytiva Collaborating on COVID-19 Rapid Test
Partnership to develop and manufacture a rapid test for the COVID-19 coronavirus infection for population screening